Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Pharm Bull (Tokyo) ; 65(7): 687-696, 2017.
Article in English | MEDLINE | ID: mdl-28674344

ABSTRACT

Total synthesis of sphingofungin E and 4,5-di-epi-sphingofungin E was achieved from an intermediate same as that of myriocin and mycestericin D via antipodal stereoselective dihydroxylations.


Subject(s)
Amino Acids/chemical synthesis , Amino Acids/chemistry , Fatty Acids, Unsaturated/chemical synthesis , Fatty Acids, Unsaturated/chemistry , Magnetic Resonance Spectroscopy , Spectrometry, Mass, Fast Atom Bombardment , Spectrophotometry, Infrared , Spectrophotometry, Ultraviolet
2.
Int J Risk Saf Med ; 23(4): 201-15, 2011.
Article in English | MEDLINE | ID: mdl-22156085

ABSTRACT

OBJECTIVE: To examine the epidemiological association between sudden deterioration leading to death and Tamiflu use. DESIGN: Proportional mortality study. SETTING: Japan. PARTICIPANTS: 162 deaths without deterioration before the first consultation among all 198 deaths of mostly confirmed 2009A/H1N1 influenza. POPULATION AT RISK: Age-specific population of influenza patients prescribed Tamiflu and Relenza. MAIN OUTCOME MEASURE: Age-stratified pooled odds ratio (OR) for early (within 12 hours) deterioration and overall death of Tamiflu prescribed to Relenza prescribed patients. RESULTS: Of 119 deaths after Tamiflu was prescribed, 38 deteriorated within 12 hours (28 within 6 hours), while of 15 deaths after Relenza, none deteriorated within 12 hours. Pooled OR for early deterioration and overall death were 5.88 (95% CI: 1.30 to 26.6, p = 0.014) and 1.91 (p = 0.031) respectively. Baseline characteristics including risk factors did not contribute to early deterioration after Tamiflu use. CONCLUSIONS: These data suggest Tamiflu use could induce sudden deterioration leading to death especially within 12 hours of prescription. These findings are consistent with sudden deaths observed in a series of animal toxicity studies, several reported case series and the results of prospective cohort studies. From "the precautionary principle" the potential harm of Tamiflu should be taken into account and further detailed studies should be conducted.


Subject(s)
Antiviral Agents/adverse effects , Death, Sudden/epidemiology , Influenza A Virus, H1N1 Subtype , Influenza, Human/drug therapy , Oseltamivir/adverse effects , Zanamivir/therapeutic use , Adolescent , Adult , Age Distribution , Aged , Antiviral Agents/therapeutic use , Child , Child, Preschool , Death, Sudden/etiology , Humans , Infant , Influenza, Human/mortality , Japan/epidemiology , Middle Aged , Oseltamivir/therapeutic use , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...